<DOC>
	<DOCNO>NCT00878501</DOCNO>
	<brief_summary>The primary aim study investigate AZD1386 efficacious analgesic patient osteoarthritis knee dose . This do comparing effect AZD1386 placebo ( `` inactive substance '' ) pain .</brief_summary>
	<brief_title>Study Evaluate Efficacy , Safety , Tolerability Pharmacokinetics AZD1386 Patients With Osteoarthritis ( OA ) Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patients OA knee Male non pregnant female 40 80 year old A current diagnosis another form arthritis , addition OA History , and/or presence somatic disease , may interfere objective</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Pain</keyword>
</DOC>